White Papers

Targeted Approach in anti cancer therapy

Targeted therapy refers to a new generation of cancer drugs designed to interfere with a specific target protein that is believed to have a critical role in tumor growth or progression

PDF Read More

Common Mistake in Adjusting Sample Size for Anticipated Dropouts in Clinical Trials

Day by day the clinical trial field is expanding like anything. New molecules are needs to be experimented in human beings and the existing drugs are needs to be monitored for long term safety. Thus Phase I to IV clinical trial activities are increasing exponentially all over the world.

PDF Read More

Clinical Oversight

Recently, U.S. Food and Drug Administration (FDA) issued Warning Letters to pharmaceutical companies and their outsourcing partners have resulted to focus on clinical oversight. The letters have galvanized sponsors to take a close look at their ability to withstand such regulatory scrutiny internally, and to develop proactively their internal capabilities and infrastructure

PDF Read More

cQRM (clinical Quality Risk Management)

cQRM is a risk management methodology that applies quality risk management to clinical trials. It focuses on proactive risk management in clinical research and helps in completing clinical trials successfully within the timelines and budget.

PDF Read More

Carcinoid Syndrome - Research Perspective

Carcinoid syndrome is a collective of symptoms that occurs in patients with Carcinoid tumor. It is caused by excessive endogenous secretion of hormones mainly serotonin and kallikrein. The syndrome includes flushing and diarrhea, and, less frequently, heart failure and bronchoconstriction.

PDF Read More

Have Questions? Need Info/Quotes?